Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

A phase I study evaluating tolerability, pharmacokinetics, and preliminary efficacy of L-menthol in upper gastrointestinal endoscopy.

Hiki N, Kaminishi M, Hasunuma T, Nakamura M, Nomura S, Yahagi N, Tajiri H, Suzuki H.

Clin Pharmacol Ther. 2011 Aug;90(2):221-8. doi: 10.1038/clpt.2011.110. Epub 2011 May 4.

PMID:
21544078
[PubMed - indexed for MEDLINE]
2.

An open-label, single-arm study assessing the efficacy and safety of L: -menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy.

Hiki N, Kaminishi M, Tanabe S, Fujisaki J, Yoshino J, Iguchi M, Kobayashi H, Ashida K, Kawabe T, Kawano T, Nomura S, Yahagi N, Tajiri H, Suzuki H.

J Gastroenterol. 2011 Jul;46(7):873-82. doi: 10.1007/s00535-011-0395-9. Epub 2011 May 11.

PMID:
21559772
[PubMed - indexed for MEDLINE]
3.

Multicenter phase II randomized study evaluating dose-response of antiperistaltic effect of L-menthol sprayed onto the gastric mucosa for upper gastrointestinal endoscopy.

Hiki N, Kaminishi M, Yasuda K, Uedo N, Kobari M, Sakai T, Hiratsuka T, Ohno K, Honjo H, Nomura S, Yahagi N, Tajiri H, Suzuki H.

Dig Endosc. 2012 Mar;24(2):79-86. doi: 10.1111/j.1443-1661.2011.01163.x. Epub 2011 Jun 1.

PMID:
22348831
[PubMed - indexed for MEDLINE]
4.

Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.

Hiki N, Kaminishi M, Yasuda K, Uedo N, Honjo H, Matsuhashi N, Hiratsuka T, Sekine C, Nomura S, Yahagi N, Tajiri H, Suzuki H.

Gastrointest Endosc. 2011 May;73(5):932-41. doi: 10.1016/j.gie.2010.12.013. Epub 2011 Feb 26.

PMID:
21353674
[PubMed - indexed for MEDLINE]
5.

Pharmacology and preclinical pharmacokinetics of peppermint oil.

Grigoleit HG, Grigoleit P.

Phytomedicine. 2005 Aug;12(8):612-6. Review.

PMID:
16121523
[PubMed - indexed for MEDLINE]
6.

Metabolic fate of [3H]-l-menthol in the rat.

Yamaguchi T, Caldwell J, Farmer PB.

Drug Metab Dispos. 1994 Jul-Aug;22(4):616-24.

PMID:
7956738
[PubMed - indexed for MEDLINE]
7.

Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.

Nolen HW 3rd, Friend DR.

Pharm Res. 1994 Dec;11(12):1707-11.

PMID:
7899232
[PubMed - indexed for MEDLINE]
8.
9.

Simple measurement of gluconeogenesis by direct 2H NMR analysis of menthol glucuronide enrichment from 2H2O.

Ribeiro A, Caldeira MM, Carvalheiro M, Bastos M, Baptista C, Fagulha A, Barros L, Barosa C, Jones JG.

Magn Reson Med. 2005 Aug;54(2):429-34.

PMID:
16032678
[PubMed - indexed for MEDLINE]
10.
11.

Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates.

Thomassen D, Pearson PG, Slattery JT, Nelson SD.

Drug Metab Dispos. 1991 Sep-Oct;19(5):997-1003.

PMID:
1686249
[PubMed - indexed for MEDLINE]
12.

The inhibition of bone resorption in rats treated with (-)-menthol is due to its metabolites.

Spichiger M, Brenneisen R, Felix R, Mühlbauer RC.

Planta Med. 2006 Nov;72(14):1290-5. Epub 2006 Oct 4.

PMID:
17021997
[PubMed - indexed for MEDLINE]
13.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571
[PubMed - indexed for MEDLINE]
14.

Biotransformation of 1,8-cineole in the brushtail possum (Trichosurus vulpecula).

Boyle R, McLean S, Davies NW.

Xenobiotica. 2000 Sep;30(9):915-32.

PMID:
11055269
[PubMed - indexed for MEDLINE]
15.

Disposition kinetics and effects of menthol.

Gelal A, Jacob P 3rd, Yu L, Benowitz NL.

Clin Pharmacol Ther. 1999 Aug;66(2):128-35.

PMID:
10460066
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.

Webber C, Roth A, Persiani S, Peard AJ, Makovec F, Kapil RP, John BA, Holding JD, D'amato M, Cybulski ZR, Chasseaud LF, Rovati LC.

Xenobiotica. 2003 Jun;33(6):625-41.

PMID:
12851039
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetic profile of nicorandil in humans: an overview.

Frydman A.

J Cardiovasc Pharmacol. 1992;20 Suppl 3:S34-44.

PMID:
1282174
[PubMed - indexed for MEDLINE]
18.

Direct high-performance liquid chromatography determination of propofol and its metabolite quinol with their glucuronide conjugates and preliminary pharmacokinetics in plasma and urine of man.

Vree TB, Lagerwerf AJ, Bleeker CP, de Grood PM.

J Chromatogr B Biomed Sci Appl. 1999 Jan 22;721(2):217-28.

PMID:
10052694
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.

Clin Ther. 2006 Jan;28(1):55-72.

PMID:
16490580
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.

Chen X, Cui L, Duan X, Ma B, Zhong D.

Drug Metab Dispos. 2006 Aug;34(8):1345-52. Epub 2006 May 19.

PMID:
16714374
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk